Chief among them is BPC-157, a compound hailed by some as a breakthrough for injury recovery and tissue repair
Common side effects of BPC-157 arent usually serious and may include: Mild injection site reactions (itching, redness, swelling, pain, etc.) Headaches Dizziness Nausea In rare cases, patients may experience fevers, blistering at the injection site, muscle aches, rashes, vomiting, hives, or other signs of an allergic reaction
Huang et al., 2015) was successfully applied to the other tissues healing (and thereby avoiding all shortages related to the peptide + carrier complex(es) (standard angiogenic growth factors application with diverse carriers)) (see Practical Application as Support )
With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026
They didnt